Abstract
A non-human like glycosylation pattern in human recombinant glycoproteins expressed by animal cells may compromise their use as therapeutic drugs. In order to correct the CHO glycosylation machinery, a CHO cell line producing recombinant human interferon- γ (IFN) was transformed to replace the endogenous pseudogene with a functional copy of the enzyme α2,6-sialyltransferase (α2,6-ST). Both the parental and the modified CHO cell line were propagated in serum-free batch culture with or without 1 mM sodium butyrate. Although Na-butyrate inhibited cell growth, IFN concentration was increased twofold. The IFN sialylation status was determined using linkage specific sialidases and HPLC. Under non- induced conditions, IFN expressed by α2,6-engineered cells contained 68% of the total sialic acids in the α2,6- conformation and the overall molar ratio of sialic acids to IFN was 2.3. Sodium butyrate addition increased twofold the molar ratio of total sialic acids to IFN and 82% of total sialic acids on IFN were in the α2,6-conformation. In contrast, no effect of the sodium butyrate was noticed on the sialylation of the IFN secreted by the α2,6-ST deficient parental cell line. This study deals for the first time with the effect of Na-butyrate on CHO cells engineered to produce human like sialylation.
Similar content being viewed by others
References
Arts J, Lansink M, Grimbergen J, Toet KH and Kooistar, T (1995) Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothetial cells involves histone acetylation. Biochem J 310: 171-176.
Chevalot I, Dardenne M, Cherlet M, Engasser J-M and Marc A (1995) Effect of sodium butyrate on protein production in different culture systems. In: Beuvery EC, Spier R and Griffiths B (eds) Animal Cell Technology: Developments towards the 21st Century, Kluwer Academic Publishers, Dordrecht, pp. 143-147.
Chevalot I, Visvikis A, Nabet P, Engasser J-M and Marc A (1994) Production of a membrane-bound protein, the human gammaglutamyl transferase, by CHO cells cultivated on microcarriers, in aggregates and in suspension. Cytotechnology 16: 121-129.
Chotigeat W, Watanapokasin Y, Malher S and Gray PP (1994) Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase for hFSH produced by recombinant CHO cells. Cytotechnology 15: 217-221.
Cole ES, Nichols EH, Poisson L, Harnois ML and Livingston DJ (1993) In vivo clearance of tissue plasminogen-activator — The complex role of sites and level of sialylation. Fibrinolysis 7: 15-27.
Dorner AJ, Wasley LC and Kaufman RJ (1989) Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated chinese hamster ovary cells. J Biol Chem 264: 20602-20607.
Dickramer K (1991) Clearing up glycoprotein hormones. Cell 67: 1029-1032.
Fillipovitch I, Sorokina N, Khanna KK and Lavin MF (1994) Butyrate induced apoptosis in lymphoid cells preceded by transient over-expression of HSP70 mRNA. Biochem Biophys Res Comm 198: 257-265.
Flesher ER, Marzowski J, Wang WC and Raff HV (1995) Fluorophore labelled glycan analysis of immunoglobulin fusion proteins: correlation of oligosaccharide content with in vivo clearance profile. Biotechnol Bioeng 46: 399-407.
Gebert CA and Gray PP (1995) Expression of FSH in CHO cells. 2. Stimulation of hFSH expression levels by defined medium supplements. Cytotechnology 17: 13-19.
Goergen J-L, Marc A, Engasser J-M, Rabaud J-N, Pierry G, Geaugey V, Geahel I and Hache J (1994) Development of a new membrane reactor for large scale mammalian cell culture. In: Spier RE, Griffiths JB and Berthold W (eds) Animal Cell Technology: Products of Today, Prospects for Tomorrow, Butterworth-Heinemann, London, pp. 287-290.
Grabenhorst E, Hoffman A, Nimtz M, Zettlmeissl G and Conradt HS (1995) Construction of stable BHK-21 cells coexpressing human secretory glycoproteins and human Gal(β1-4)GlcNAc-R α2,6-sialyltransferase. Eur J Biochem 232: 718-725.
Gramer M, Goochee C, Chock V, Brousseau D and Sliwkowski M (1995) Removal of sialic acid from a glycoprotein in CHO cell culture supernatant by action of an extracellular CHO cell sialidase. Bio/technology 13: 692-698.
Gray PW, Leung DW, Pennica D, Yelverton E, Najarian R, Simonsen CC, Derynck R, Sherwood PJ, Wallace DM, Berger SL, Levinson AD and Goeddel DV (1982) Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 295: 503-508.
Gu X, Harmon BJ and Wang DIC (1997) Site-and branch-specific sialylation of recombinant human interferon-g in Chinese hamster ovary cell culture. Biotechnol Bioeng 55: 390-398.
Hayter PM, Curling EMA, Baines AJ, Jenkins N, Salmon I, Strange PG and Bull AT (1991) Chinese hamster ovary cell growth and interferon production kinetics in stirred batch culture. Appl Microb Biotechnol 34: 559-564.
Hodgson, J (1993) Expression systems: A user's guide. Bio/technology 11: 887-893.
Hooker AD, Green NH, James DC, Strange PG, Baines AJ, Bull AT and Jenkins N (1997) Epitope determination for antibodies raised against recombinant human interferon-γ. In: Carrondo MJT, Griffiths B and Moreira JLP (eds) Animal Cell Technology: From Vaccines to Genetic Medicine, Kluwer Academic Publishers, Dordrecht, pp. 277-282.
Hooker AD, Goldman MH, Markham NH, James DC, Ison AP, Bull AT, Strange PG, Salmon I, Baines AJ and Jenkins, N (1995) N-glycans of recombinant human interferon-γ change during batch culture of Chinese-hamster ovary cells. Biotechnol Bioeng 48: 639-648.
James DC, Freedman RB, Hoare M, Ogonah OW, Rooney BC, Larionov OA, Dobrovolsky VN, Lagutin OV and Jenkins N (1995) N-glycosylation of recombinant human interferon-γ produced in different animal expression systems. Bio/technology 13: 592-596.
Jenkins N, Parekh RB and James DC (1996) Getting the glycosylation right: implications for the biotechnology industry. Nature Biotechnology 14: 975-981.
Jenkins N, Castro PML, Menon S, Ison A and Bull AT (1994) Effect of lipid supplements on the production and glycosylation of recombinant interferon-γ expressed in CHO cells. Cytotechnology 15: 209-215.
Kelm S, Schauer R, Manuguerra JC, Gross HJ and Crocker PR (1995) Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22. Glycoconjugate J 11: 576-585.
Kruh J (1982) Effects of sodium butyrate, a new pharmaceutical agent, on cells in culture. Mol Cell Biochem 42: 65-82.
Lamotte D, Eon-Duval A, Acerbis G, Distefano G, Monaco L, Soria M, Jenkins N, Engasser J-M and Marc A (1997) Controlling the glycosylation of recombinant proteins expressed in animal cells by genetic and physiological engineering. In: Carrondo MJT, Griffiths B and Moreira JLP (eds) Animal Cell Technology: From Vaccines to Genetic Medicine, Kluwer Academic Publishers, Dordrecht, pp. 761-765.
Lao MS, Toth D, Danell G and Schalla C (1996) Degradative activities in a recombinant Chinese hamster ovary cell culture. Cytotechnology 22: 43-52.
Lee UE, Roth J and Paulson JC (1989) Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of β-galactoside α2,6-sialyltransferase. J Biol Chem 164: 13848-13855.
Li M, Andersen ML and Lance P (1995) Expression and regulation of glycosyltransferases for N-glycosyl oligosaccharides in fresh human surgical and murine tissues and cultured cell lines. Clin Sci 89: 397-404.
Lodish HF (1991) Recognition of complex oligosaccharides by the multi-subunit asialoglycoprotein receptor. Trends Biochem Sci 16: 374-377.
Lourenço da Silva A, Marc A, Engasser J-M and Goergen J-L (1996) Kinetic model of hybridoma cultures for the identification of rate limiting factors and process optimisation. Math Comp Sim 42: 197-205.
Meager A and Leist T (1986) Antigenic characteristics of glycosylated natural and unglycosylated recombinant human gammainterferon. J Interferon Res 6: 225-232.
Monaco L, Marc A, Eon-Duval A, Acerbis G, Distefano G, Lamotte D, Engasser J-M, Soria M and Jenkins N (1996) Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effect on the sialylation of recombinant interferon-γ. Cytotechnology 22: 197-203.
Monaco L, Tagliabue R, Soria MR and Uhlèn M (1994) An in vitro approach for the expression of recombinant proteins in mammalian cells. Biotechnol Appl Biochem 20: 157-171.
Munzert E, Müthing J, Büntemeyer H and Lehman J (1996) Sialidase activity in culture fluid of Chinese hamster ovary cells during batch culture and its effect on recombinant human antithrombin III integrity. Biotechnol Prog 12: 559-563.
Oh SKW, Vig P, Chua F, Teo WK and Yap MGS (1993) Substantial overproduction of antibodies by applying osmotic pressure and sodium butyrate. Biotechnol Bioeng 42: 601-610.
Oster T, Thioudellet C, Chevalot I, Masson C, Wellman M, Marc A and Siest G (1993) Induction of recombinant gamma-glutamyl transferase by sodium butyrate in transfected V79 and CHO chinese hamster cells. Biochem Biophys Res Comm 193: 406-412.
Palermo DP, DeGraaf ME, Marotti KR, Rehberg E and Post LE (1991) Production of analytical quantities of recombinant proteins in chinese hamster ovary cells using sodium butyrate to elevate gene expression. J Biotechnol 19: 35-48.
Reuter G and Schauer R (1994) Determination of sialic acids. Methods Enzymol 230: 168-199.
Rinderknecht E, O'Connor BH and Rodriguez H (1984) Natural human interferon-γ. Complete amino sequence and determination of sites of glycosylation. J Biol Chem 259: 6790-6797.
Rocchi P, Ferreri AM, Simone G, Granchi D, Paolucci P and Paolucci G (1992) Growth inhibitory and differentiating effects of sodium butyrate on human neuroblastoma cells in culture. Anticancer Res 12: 917-920
Saito H, Kagawa T, Tada S, Tsunematsu S, Guevara FM, Watanabe T, Morizane T and Tsuchiya M (1992) Effect of dexamethasone, dimethylsulfoxide and sodium butyrate on a human hepatoma cell line PLC/PRF/5. Cancer Biochem Biophys 13: 75-84.
Sareneva T, Pirhonen J, Cantell K and Julkunen I (1995) N-glycosylation of human interferon-γ: glycans at Asn-25 are critical for protease resistance. Biochem J 308: 9-14.
Sareneva T, Pirhonen J, Cantell K, Kalkkinen N and Julkunen I (1994) Role of N-glycosylation in the synthesis, dimerization and secretion of human interferon-γ. Biochem J 303: 831-840.
Sareneva T, Cantell K, Pyhäla L, Pirhonen J and Julkunen I (1993) Effect of carbohydrates on the pharmacokinetics of human interferon-γ. J Interferon Res 13: 267-269.
Shadan FF, Cowsert LM and Villarbeal LP (1994) n-Butyrate, a cell cycler blocker, inhibits the replication of polyomaviruses and papillomaviruses but not that of adenoviruses and herpesvirus. J Virol 68: 4785-4796.
Shah S, Lance P, Smith TJ, Berenson CS, Cohen SA, Horvath PJ, Lau JTY and Baumann H (1995) n-butyrate reduces the expression of β-galactoside α2,6-sialyltransferase in Hep G2 cells. J Biol Chem 267: 10652-10658.
Smith TJ, Piscatelli JJ, Andersen V, Wang H-S and Lance P (1996) n-butyrate induces plasminogen activator inhibitor type 1 messenger RNA in cultured Hep G2 cells. Hepatology 23: 866-871.
Smith PJ (1986) n-butyrate alters chromatin accessibility to DNA repair enzymes. Carcinogenesis 7: 423-429.
Wagner A, Marc A and Engasser J-M (1992) The use of lactate dehydrogenase (LDH) release kinetics for the evaluation of death and growth of mammalian cells in perfusion reactors. Biotechnol Bioeng 39: 320-326.
Yamada K, Ohtsu M, Sugano M and Kimura G (1992) Effects of butyrate on cell cycle progression and polyploidization of various types of mammalian cells. Biosci Biotech Biochem 56: 1261-1265.
Yamamoto I, Matsunaga T, Sakata K, Nakamura Y, Doi S and Hanmyou F (1996) Histone hyperacetylation plays a role in augmentation of IL-4-induced IgE production in LPS-stimulated murine B-lymphocytes by sodium butyrate. J Biochem 119: 1056-1061.
Young HA and Hardy KJ (1995) Role of interferon-γ in immune cell regulation. J Leuk Biol 58: 373-381.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lamotte, D., Buckberry, L., Monaco, L. et al. Na-butyrate increases the production and α2,6-sialylation of recombinant interferon-γ expressed by α2,6- sialyltransferase engineered CHO cells. Cytotechnology 29, 55–64 (1999). https://doi.org/10.1023/A:1008080432681
Issue Date:
DOI: https://doi.org/10.1023/A:1008080432681